Prognostic and Predictive Factors in Newly Diagnosed Multiple Myeloma Patients with Early Mortality with Prediction Matrix and Three and Five-Year Overall Survival
Survival rates for newly diagnosed multiple myeloma have increased to a remarkable 8–12 years. Novel agents, autologous stem cell transplantation, monoclonal antibodies, improvements in supportive care and attention to minimal residual disease negative all have aided this remarkable journey. With th...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book Chapter |
| Language: | English |
| Published: |
IntechOpen
2021
|
| Subjects: | |
| Online Access: | https://www.intechopen.com/chapters/74998 |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Prognostic and Predictive Factors in Newly Diagnosed Multiple Myeloma Patients with Early Mortality with Prediction Matrix and Three and Five-Year Overall Survival
- Treatment of Patients with Newly-Diagnosed Multiple Myeloma
- Morphology-Aware Prognostic model for Five-Year Survival Prediction in Colorectal Cancer from H&E Whole Slide Images
- Novel Prognostic Modalities in Multiple Myeloma
- Transfer Learning and Machine Learning for Training Five Year Survival Prognostic Models in Early Breast Cancer
- Glioblastoma Overall Survival Prediction With Vision Transformers
- MMMNA-Net for Overall Survival Time Prediction of Brain Tumor Patients